Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% |
|
-4.00% | +9.09% |
01/07 | PYC Therapeutics Advances Trial for Drug Candidate; Shares Up 4% | MT |
18/06 | Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 37Cr | |
+16.77% | 4.49TCr | |
-10.63% | 3.78TCr | |
+40.83% | 3.76TCr | |
+28.94% | 3.13TCr | |
-8.44% | 2.74TCr | |
+12.13% | 2.63TCr | |
+41.50% | 1.41TCr | |
+32.42% | 1.25TCr | |
-6.73% | 1.12TCr |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Advances Trial for Drug Candidate; Shares Up 4%